Onyx Biotec Limited (NSE:ONYX)
India · Delayed Price · Currency is INR 37.25
+0.20 (0.54%)
At close: Oct 16, 2026
Onyx Biotec Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 40.37 | 86.12 | 14.67 | 0.07 | 0.14 |
Cash & Short-Term Investments | 40.37 | 86.12 | 14.67 | 0.07 | 0.14 |
Cash Growth | -53.12% | 487.13% | 19721.62% | -45.59% | - |
Accounts Receivable | 246.01 | 202.32 | 153.73 | 50.76 | 84.17 |
Other Receivables | 29.49 | - | - | 0.86 | 0.38 |
Receivables | 275.5 | 202.32 | 153.73 | 51.61 | 84.55 |
Inventory | 140.4 | 161 | 91.03 | 63.29 | 30.53 |
Prepaid Expenses | 1.3 | 1.97 | 0.84 | 0.67 | 0.53 |
Other Current Assets | 55.21 | 40.47 | 35.32 | 30 | 28.58 |
Total Current Assets | 512.78 | 491.88 | 295.58 | 145.64 | 144.32 |
Property, Plant & Equipment | 428.35 | 409 | 434.77 | 425.04 | 212.58 |
Long-Term Investments | 7.24 | 6.82 | 6.4 | 11.98 | 8.01 |
Other Long-Term Assets | 3.17 | 4.78 | 4.6 | 4.57 | 3.48 |
Total Assets | 951.55 | 912.48 | 741.36 | 587.24 | 368.38 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 176.46 | 167.31 | 137.86 | 69.23 | 43.16 |
Accrued Expenses | 22.38 | 19.66 | 9.14 | 14.85 | 17.7 |
Short-Term Debt | 90.56 | 40.97 | 29.24 | 72.99 | 12.43 |
Current Portion of Long-Term Debt | 14.26 | 16.05 | 42.65 | 39.14 | 23.71 |
Current Income Taxes Payable | - | 10.02 | 2.73 | - | - |
Other Current Liabilities | 21.61 | 3.28 | 3.84 | 5.87 | 3.32 |
Total Current Liabilities | 325.27 | 257.28 | 225.46 | 202.08 | 100.32 |
Long-Term Debt | 46.89 | 67.57 | 235.91 | 180.16 | 86.3 |
Pension & Post-Retirement Benefits | - | - | - | 4.36 | 3.81 |
Long-Term Deferred Tax Liabilities | 25.3 | 31.41 | 27.11 | 18.63 | 14.2 |
Other Long-Term Liabilities | 0 | 0 | - | - | - |
Total Liabilities | 397.47 | 356.26 | 488.48 | 405.22 | 204.63 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 181.32 | 181.32 | 133.22 | 59.02 | 59.02 |
Additional Paid-In Capital | 226.97 | 226.97 | 21.27 | 2.19 | 2.19 |
Retained Earnings | 145.79 | 147.93 | 98.39 | 120.81 | 102.55 |
Shareholders' Equity | 554.08 | 556.22 | 252.88 | 182.02 | 163.76 |
Total Liabilities & Equity | 951.55 | 912.48 | 741.36 | 587.24 | 368.38 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 151.71 | 124.58 | 307.8 | 292.28 | 122.44 |
Net Cash (Debt) | -111.34 | -38.46 | -293.14 | -292.21 | -122.3 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -6.14 | -2.57 | -24.56 | -24.76 | -10.36 |
Filing Date Shares Outstanding | 18.13 | 18.13 | 13.32 | 11.8 | 11.8 |
Total Common Shares Outstanding | 18.13 | 18.13 | 13.32 | 11.8 | 11.8 |
Working Capital | 187.51 | 234.6 | 70.13 | -56.43 | 44 |
Book Value Per Share | 30.56 | 30.68 | 18.98 | 15.42 | 13.87 |
Tangible Book Value | 554.08 | 556.22 | 252.88 | 182.02 | 163.76 |
Tangible Book Value Per Share | 30.56 | 30.68 | 18.98 | 15.42 | 13.87 |
Land | 18.87 | 18.87 | - | 18.87 | 7.85 |
Buildings | 123.13 | 121.58 | - | 121.33 | 64.08 |
Machinery | 476.66 | 465.11 | - | 428.83 | 231.25 |
Construction In Progress | 36.76 | - | - | - | 40.23 |